
Start-up receives $4m towards ‘one-shot’ cancer drug
A drug discovery company co-founded by researchers at the University of Dundee and the University of Arizona has received $4 million in venture funding. Branch Therapeutics, founded in November 2024, is a preclinical stage company seeking to develop drugs that are orally bioavailable, well-tolerated, and can treat multiple cancer types. … Read More

